Mater Private raises the bar in cancer care

Mater Private Network has become the first in Ireland to introduce TrueBeam LINACs with HyperSight, investing €5.6 million to deliver sharper imaging and faster radiotherapy treatments. This technology, now in place at its Dublin hospital and soon in Limerick, promises greater precision in tumour targeting, fewer side effects, and shorter treatment times.

The investment forms part of the group’s €20 million commitment over five years to enhance cancer services, positioning Mater Private at the forefront of private oncology care. For c-suite leaders, it underscores the competitive edge of adopting advanced clinical technologies to improve outcomes and attract patients seeking world-class treatment closer to home.

Read the full article for insights on technology-driven care leadership.